VYGR

NASDAQ open

Voyager Therapeutics

1.56 USD
▼-0.05-3.11%
盘后 1.72 0.00%
2026-11-20
市值
$95.21M
市盈率
—
EPS
-1.74
股息率
—
52 周区间
1.48 – 5.48
成交量
302.11K
Beta
1.17
目标价
14.22
52W 低 1.4852W 高 5.48
价格走势

公司简介

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small mo...